ATE175977T1 - Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen - Google Patents

Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen

Info

Publication number
ATE175977T1
ATE175977T1 AT9595108681T AT95108681T ATE175977T1 AT E175977 T1 ATE175977 T1 AT E175977T1 AT 9595108681 T AT9595108681 T AT 9595108681T AT 95108681 T AT95108681 T AT 95108681T AT E175977 T1 ATE175977 T1 AT E175977T1
Authority
AT
Austria
Prior art keywords
amino acid
acid sequence
affinity
radioactive
peptide
Prior art date
Application number
AT9595108681T
Other languages
English (en)
Inventor
Ikuya Seki
Yoshitoshi Itaya
Yoshifumi Shirakami
Komei Washino
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of ATE175977T1 publication Critical patent/ATE175977T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT9595108681T 1994-06-07 1995-06-06 Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen ATE175977T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14865594 1994-06-07

Publications (1)

Publication Number Publication Date
ATE175977T1 true ATE175977T1 (de) 1999-02-15

Family

ID=15457667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9595108681T ATE175977T1 (de) 1994-06-07 1995-06-06 Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen

Country Status (11)

Country Link
US (1) US5827498A (de)
EP (1) EP0700930B1 (de)
KR (1) KR960000250A (de)
AT (1) ATE175977T1 (de)
AU (1) AU684348B2 (de)
CA (1) CA2151099A1 (de)
DE (1) DE69507408T2 (de)
DK (1) DK0700930T3 (de)
ES (1) ES2138111T3 (de)
MC (1) MC2397A1 (de)
TW (1) TW394777B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
ES2804476T3 (es) * 2010-12-14 2021-02-08 Recepta Biopharma S A Péptido antitumoral derivado de una región determinante de complementariedad de un anticuerpo monoclonal humanizado contra el transportador NaPI2B
CN104519898A (zh) 2012-06-06 2015-04-15 国家健康与医学研究院 用于治疗癌症的方法和药物组合物
CN111225679B (zh) * 2017-08-19 2024-03-29 俄亥俄州创新基金会 新型基于肽的癌症显像剂
CN107550864B (zh) * 2017-08-23 2020-12-18 科笛生物医药(上海)有限公司 Eppt多肽-聚乙二醇-磷脂复合膜材料、其制备方法及主动靶向脂质体递药系统和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
JPH04501719A (ja) * 1988-11-10 1992-03-26 インペリアル・キヤンサー・リサーチ・テクノロジー・リミテツド ポリペプチド
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds

Also Published As

Publication number Publication date
ES2138111T3 (es) 2000-01-01
US5827498A (en) 1998-10-27
KR960000250A (ko) 1996-01-25
TW394777B (en) 2000-06-21
DE69507408D1 (de) 1999-03-04
DE69507408T2 (de) 2000-05-18
CA2151099A1 (en) 1995-12-08
AU684348B2 (en) 1997-12-11
EP0700930A1 (de) 1996-03-13
DK0700930T3 (da) 1999-09-13
MC2397A1 (fr) 1996-07-26
EP0700930B1 (de) 1999-11-03
AU2049995A (en) 1995-12-14

Similar Documents

Publication Publication Date Title
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
MX9707430A (es) Complejos radiofarmaceuticos ternarios.
ES2146213T3 (es) Compuestos de porficeno para terapia fotodinamica.
AU579387B2 (en) New tetrapyrrole therapeutic agents
DK197386A (da) Terapeutiske praeparater til brug ved fotodiagnose og fototerapi
DE69518083D1 (de) Von peptiden abgeleitete komplexbildner für radionuklide
EP1289571A2 (de) Prochelators von radiometall markierte molekülen
AU2001277488A1 (en) Prochelators of radiometal labeled molecules
ATE175977T1 (de) Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen
ES2096040T3 (es) Nuevo reactivo para la representacion grafica de los tumores y su terapia.
GR1002903B (el) Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
EP0659764B1 (de) Peptide modifiziert durch eine Phosphin Gruppe zur Markierung mit 99mTC und 186-188Re oder paramagnetische Agentien
ATE89567T1 (de) Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.
US5798444A (en) Ligand precursors for incorporation into peptides
IL86722A (en) Guanidine-related compounds comprising a tetraphenylborate ion and their preparation
KR970704682A (ko) 테크네튬-술폰아미드 착물, 이들의 용도, 이들을 함유하는 약제, 및 상기 착물 및 약제의 제조 방법(Technetium-Sulphonamide Complexes, Their Use, Pharmaceutical Agents Containing Them, and Process for Producing the Complexes and Agents)
CA2172455A1 (en) Labelled compound
DE4433572A1 (de) Neue Kontrastmittel für die Röntgen-, Magnetresonanz- und Nukleardiagnostik, deren Herstellung und Verwendung
Jones Method of synthesis of vicinal diamines
JPH04149198A (ja) カルシトニン誘導体
IT1245352B (it) Mezzi di contrasto per imaging cardiaco
RU93048177A (ru) Новые 2-сахаринилметиларилкарбоксилаты, полезные в качестве ингибиторов протеолитических ферментов, и использование указанных соединений и композиция на их основе